Cormorant Asset Management LP 13D and 13G filings for AVEO Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 3:07 pm Sale |
2020-12-31 | 13G | AVEO Pharmaceuticals, Inc. AVEO |
Cormorant Asset Management LP | 0 0.000% |
-1,350,000 (Position Closed) |
Filing |
| 2020-06-29 5:22 pm Unchanged |
2020-06-17 | 13G | AVEO Pharmaceuticals, Inc. AVEO |
Cormorant Asset Management LP | 1,350,000 5.230% |
0 (Unchanged) |
Filing |
| 2020-06-29 5:22 pm Purchase |
2020-06-17 | 13G | AVEO Pharmaceuticals, Inc. AVEO |
Cormorant Asset Management LP | 1,350,000 5.230% |
1,350,000 (New Position) |
Filing |